Pharma BD Deal Intelligence
Lilly / Vaccine Company
2026 · Acquisition/Merger · $1.6B · Pending
This deal is too recent to grade. Critic Score and Outcome Score are assigned after the announcement-week coverage settles and, for Outcome, after the 5-year post-close assessment window opens — expected 2031 at the earliest for this deal, once/if it closes.
Key facts
- Announced May 26, 2026
- Deal value $1.6B
- Deal type Acquisition/Merger
Related deals
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals
More: 2026 deals · Lilly deals